alpha-stim® AID Take Charge of Anxiety, Insomnia and Depression* with Alpha-Stim AID An FDA-cleared, non-drug CES device designed to provide sustainable, long-term relief. *FDA cleared for anxiety, insomnia and pain only, with approval for depression outside of the United States. Alpha Stim AID

Alpha-Stim Aid

Take Charge of
anxiety, insomnia
and depression*

Ragga-52-525x684

Alpha-Stim® AID Features

Proven to Help with Anxiety,
Insomnia & Depression

overall decrease in anxiety

Overall Decrease in Anxiety

In clinical trials, patients reported an average of 61% less anxiety immediately after using the CES therapy. After 5 weeks, that average was 94%.1
results in one application

Results in 1 Application

In a study of preoperative anxiety, Alpha-Stim recipients reported significantly less anxiety after one 20-minute treatment.2

increased sleep time

Increased Sleep Time

After only 5 treatments, military Service Members with insomnia reported an increase of 43 minutes of sleep.3
improved sleep quality

Improved Sleep Quality

The number of subjects rating their quality of sleep as poor dropped from 60% to 5%. 4
decrease in depression

Decrease in Depression

In clinical trials, Alpha-Stim recipients reported an 82% decrease of ≥ 50% or greater in depression scores after five weeks using the CES therapy.

Hear What People Are Saying About Alpha-Stim®

Ragga-Ragnars

“As a mom and having the unstable job of being an actress, who sometimes needs to travel all over the world to work, it can be demanding and at times quite stressful. I never thought of myself as having anxiety the way it was usually described to me but when I think back to a few months ago, and throughout the pandemic (where projects fell through and a lot of uncertainty with my job was a constant for quite some time) I can say now that I have indeed experienced bursts of anxiety.

After getting Alpha-Stim and using it for 20 minutes every day (I have had it for over 6 months now) it is safe to say that my stress and anxiety have decreased so much. I am more calm and focused when dealing with the day to day mom life, I am at ease when I travel and need help from my family with my son (my friends and my parents have been amazing at bringing my son to me when I am away working, or taking care of him at home while I am away) and before, that would stress me out a lot. Now, I go through my days with minimum stress and anxiety and absolutely love my Alpha-Stim for it.”

Ragga Ragnars, Actress, Former Olympic Swimmer

Ragga-Ragnars

Take Charge of Your Life

Manage anxiety, insomnia, and depression without medication and anywhere, anytime with Alpha-Stim AID.

A Technology Patients & Providers Trust

Alpha-Stim has been helping hundreds of thousands of people take charge of their anxiety, insomnia, and pain. Alpha-Stim technology has led the way with innovative non-drug neuromodulation devices. Alpha-Stim AID and Alpha-Stim M devices are highly praised by both patients and providers.

Take charge of your life with alpha-stim

telehealth

Visit

See if Alpha-Stim is right for you via a telehealth visit with a licensed healthcare provider

shop

online

Purchase Alpha-Stim devices and accessories in our online store

talk with

our team

Speak with a
representative on the
phone to learn more

Commonly Asked Questions about Alpha-Stim AID

We’ve gotten a few questions over the years about how Alpha-Stim AID. See below for some of our most common questions and answers. 

Is Alpha-Stim a VNS device?

No. Alpha-Stim is a CES device. Due to the similarity in using an electrical current or earclip electrode application, Alpha-Stim can commonly be misidentified as a VNS device or auricular vagus nerve stimulation (aVNS) devices. And while Alpha-Stim does interact with the vagus nerve, there are key differences in the types of stimulation Alpha-Stim utilizes and the brain regions it targets. 

Learn more about the differences here.

Yes.

Alpha-Stim isn’t specifically designed to target the vagus nerve like dedicated vagus nerve stimulation (VNS) devices. However, its cranial electrotherapy stimulation (CES) does engage neural pathways that include vagal function (the vagus nerve), which may contribute to some of the clinical benefits seen with the device. 

To better understand how Alpha-Stim works, Ryan Gober, PhD, the Medical Science Liaison at Electromedical Products International, explains:

“Alpha-Stim uses a low intensity, patented waveform delivered through bilateral earclip electrodes to modulate cortical activity in the temporal lobe of the brain and to stimulate nearby key cranial nerves, including the vagus, trigeminal, and vestibulocochlear nerves that project to deeper subcortical brain structures. Through these two synergistic mechanisms, Alpha-Stim has been shown to modulate activity in the default mode network (DMN), which is widely reported to exhibit altered connectivity in a number of mental health conditions, including anxiety and insomnia.”

Watch how Alpha-Stim CES works in this quick video.

Read more in this blog!

The short answer? No. See why below.

VNS devices are designed specifically to target the vagus nerve, whereas Alpha-Stim works in a broader capacity through cranial electrotherapy stimulation (CES) delivered via the earlobes. This approach interacts with vagal pathways along with other cranial nerve networks, which is part of why Alpha-Stim is FDA-cleared for the treatment of anxiety, insomnia, and pain only, with approval for depression outside of the United States.

To better understand how Alpha-Stim works, Ryan Gober, PhD, the Medical Science Liaison at Electromedical Products International, explains:

“Alpha-Stim uses a low intensity, patented waveform delivered through bilateral earclip electrodes to modulate cortical activity in the temporal lobe of the brain and to stimulate nearby key cranial nerves, including the vagus, trigeminal, and vestibulocochlear nerves that project to deeper subcortical brain structures. Through these two synergistic mechanisms, Alpha-Stim has been shown to modulate activity in the default mode network (DMN), which is widely reported to exhibit altered connectivity in a number of mental health conditions, including anxiety and insomnia.”

Read more in this blog!

Vagus nerve stimulation (VNS) and VNS devices are often promoted for improving mood, emotional regulation, depression, and pain.

Alpha-Stim does interact with the vagus nerve, but there are key differences in the types of stimulation Alpha-Stim utilizes and the brain regions it targets.

  • Alpha-Stim delivers its patented cranial electrotherapy stimulation (CES) waveform through small clips on both earlobes. While the stimulation begins at the ear, the resulting electric fields extend beyond the clip sites to influence nearby cranial nerves, including the auricular branch of the vagus nerve.

     

  • What sets Alpha-Stim apart from a VNS device is that its fields don’t stop at the nerves outside the skull; they also pass through the bone to reach cortical layers of the brain. This direct brain engagement allows Alpha-Stim to modulate activity in brain regions such as the temporal lobe and in broader brain networks that are often dysregulated in anxiety and insomnia. 

  • By influencing both cranial nerves and cortical circuits, Alpha-Stim offers a distinct mechanism that helps normalize signaling in functional networks tied to these conditions.

Read more in this blog!

Regulatory authorization differs across VNS and non-VNS devices. Alpha-Stim is FDA-cleared (Class II) with defined, labeled indications, whereas other non-invasive products are often marketed in the United States solely as general-wellness devices (GWDs) and are not cleared to treat medical conditions. Alpha-Stim CES is cleared for the treatment of anxiety and insomnia, and Alpha-Stim M’s  MET technology is cleared for pain management. 

In practical terms, FDA clearance means the device has been reviewed in accordance with applicable regulatory requirements for specific medical indications, and the manufacturer has provided supporting evidence—including performance testing and clinical data—demonstrating that the device meets FDA expectations for safety, performance, and labeling. In contrast, general wellness products are not reviewed or cleared by the FDA for specific medical claims or indications.

Always verify each device’s clearance, labeling, and supporting evidence when choosing a treatment option.

As such, Alpha-Stim offers a unique combination of mechanistic overlap with vagus nerve–targeting devices and the regulatory assurance of FDA clearance for clinical use. (Outside the United States, Alpha-Stim is approved for treating anxiety, insomnia, and pain, as well as depression.)

In conclusion, clinical research suggests Alpha-Stim CES works via a multimodal mechanism involving indirect stimulation of the vagus nerve as well as cortical brain regions that have been linked to anxiety and insomnia.

Moreover, Alpha-Stim is evidence-based, with numerous clinical studies supporting FDA clearance to treat symptoms of anxiety and insomnia as reflected in the device’s labeling. This combined stimulation of cranial nerves and cortical brain regions, along with differences in regulatory authorization, distinguishes Alpha-Stim from devices focused solely on non-invasive VNS/aVNS.

Get more information here

No. Not all CES devices are the same. And this is why researching a device is critical. Below are some things that make Alpha-Stim stand out from other CES devices in the market: 

  1. Alpha-Stim uses a patented waveform, making the stimulation it uses distinct from other CES devices.
  2. Decades of clinical evidence demonstrates safety and long-term efficacy.
  3. Alpha-Stim delivers cumulative results that build over time for long-lasting anxiety, insomnia & depression* relief.
  4. Alpha-Stim stimulates the brain to normalize the pathological signaling in the default mode network that is observed in psychiatric disorders, providing rapid, effective, and lasting symptom relief without the side effects of medication [In simpler terms, Alpha-Stim CES modulates the brain network associated with anxiety, insomnia, and depression to help bring it back to “normal”]
  5. Alpha-Stim also offers the ability to treat pain. This is another differentiator between other CES devices and Alpha-Stim.

Learn more about the science behind Alpha-Stim here >

If you’re considering stacking Alpha-Stim with another device, pause. 

Alpha-Stim is FDA-cleared to treat anxiety, insomnia, and pain, making it a strong primary treatment option. You can use Alpha-Stim along with other treatment modalities, but using it along with a VNS device or other CES device is not necessary. 

See why you don’t need a VNS device and Alpha-Stim >

Alpha-Stim is a great option to use to complement TMS though! See why here. 

Speak with your healthcare provider before using Alpha-Stim alongside other modalities or treatments. There has been no evidence of drug interaction in 40 years of research and use of Alpha-Stim. Medication change is a decision that should be discussed with your healthcare practitioner.

Sources:

  • 1 Barclay TH, Barclay RD. A clinical Trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective Disorders. 2014;164:171-177. Presented at the American Psychological Association National Conference, Honolulu, July 2013.
  • 2 Lee S-H, Kim W-Y, Lee C-H, et al. Effects of cranial electrotherapy stimulation on preoperative anxiety, pain and endocrine response. Journal of International Medical Research. 2013; 41(6) 1788–1795.

  • 3 Lande RG, Gragnani C. Efficacy of Cranial Electric Stimulation for the treatment of insomnia: A randomized pilot study. Complementary Therapies in Medicine. 2013; 21(1):8-13.

     

  • 4 Lichtbroun AS, Raicer MMC, Smith RB. The treatment of fibromyalgia with Cranial Electrotherapy Stimulation. Journal of Clinical Rheumatology. 2001; 7(2):72-78.

     

  • 5 Barclay TH, Barclay RD. A clinical Trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective Disorders. 2014; 164:171-177. Presented at the American Psychological Association National Conference, Honolulu, July 2013.
0
    0
    Your Cart
    Your cart is emptyReturn to Shop